Country for PR: China
Contributor: PR Newswire Asia (China)
Tuesday, September 22 2020 - 08:17
AsiaNet
Vection Secures First Hospital Trial
PERTH, Australia, Sept. 22, 2020 /PRNewswire-Asianet/ --

Real-time software company Vection Technologies Ltd (ASX:VR1) has signed a 
first public hospital to trial its Augmented Reality healthcare solutions. 

Vection Technologies will collaborate with the AORN S.G. Moscati hospital and 
LUISS Business School to introduce AR solutions in the Italian Model for Risk 
Management in Healthcare promoted by LUISS Business School, a national model 
that operators must adopt to manage risk in Healthcare. 

The trial will focus on integrating Vection Technologies' AR Healthcare 
solutions within the Moscati hospital, focusing on: 

- Real-time integration of data fields from endoscopic equipment in the 
surgeon's field of view, through AR wearable devices. This solution delivers a 
more precise and safer AR-based navigation system compared to conventional 
endoscopic procedures.  
- Real-time integration of electronic medical record system with AR, enabling 
healthcare professionals to access medical information through AR wearable 
devices. 

"We are pleased to have signed this initial trial with Vection Technologies to 
introduce real-time solutions within the Italian Model for Risk Management in 
Healthcare," commented Enzo Peruffo, Associate Dean for Executive Education and 
Life-Long Learning of Luiss Business School. "Augmented reality represents the 
key to the digital healthcare transformation, potentially transforming 
healthcare practices across all critical functions, from training to 
in-practice usage.

We are looking forward to support Vection, and the widespread adoption of these 
technologies, across the national health system to secure safer outcomes for 
health professionals and patients alike" 

"This initial trial represents the culmination of a lengthy regulatory process 
with key public stakeholders enabling Vection Technologies to affirm itself at 
the forefront of the digital healthcare transformation, introducing augmented 
reality as a new standard in healthcare risk management," commented Gianmarco 
Biagi, Managing Director of Vection Technologies. "This agreement represents a 
key commercial milestone setting the foundations for long-term growth, 
providing for a strong opportunity for recurring revenue growth during the 
second half of FY21 and into FY22." 

About Vection Technologies:

Vection Technologies Ltd (ASX:VR1) is a multinational software company that 
focuses on real-time technologies for industrial companies' digital 
transformation.

Through a combination of our 3D, Virtual Reality, Augmented Reality, Industrial 
IoT and CAD solutions, Vection Technologies helps companies and organisations 
to innovate, collaborate and create value.

For more information please visit the Company's websites:

vection.com.au   
mindeskvr.com 

Vection Technologies Ltd 
AUpress@vection.com.au  
+61 6380 2555

SOURCE: Vection Technologies Ltd